Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.

Doyle KP, Yang T, Lessov NS, Ciesielski TM, Stevens SL, Simon RP, King JS, Stenzel-Poore MP. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J Cereb Blood Flow Metab. 2008 Jun; 28(6):1235-48.

View in: PubMed

subject areas

Administration, Intranasal
Amino Acid Sequence
Animals
Biomimetic Materials
Cells, Cultured
Cytoprotection
Female
Humans
Integrins
Male
Mice
Molecular Sequence Data
Neurons
Neuroprotective Agents
Osteopontin
Peptides
Phosphorylation
Protein Binding
Rats
Stroke
Thrombin
Time Factors

authors with profiles

Roger simon

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support